Robert Boostanfar 医生

Robert Boostanfar 医生

Robert Boostanfar 医生在加州大学洛杉矶分校获得本科学位，随后于 1995 年毕业于南加州大学医学院。他于 1999 年完成了妇产科住院医师实习，并在生殖内分泌科和2002 年在南加州大学洛杉矶县妇女儿童医院进行的不孕症。Boostanfar 医生已在许多出版物上发表过文章，并就他在美国、加拿大和意大利的研究发表了演讲。他最近是人类生殖杂志上针对体外受精发表的最大随机对照试验的首席研究员。

Boostanfar 医生活跃于知名专业组织，包括美国妇产科腹腔镜医师协会、美国妇产科医师学会、美国生殖医学学会以及太平洋海岸生殖学会

在 Boostanfar 医生在 HRC Fertility 任职期间，他曾多次出现在电视节目中，包括“跟上卡戴珊姐妹”、早安美国、CNN、学习频道作为“小夫妻”、KTLA、CBS 的住院医生，并且一直是在人物杂志和时尚杂志上刊登。Boostanfar 博士获得了无数奖项，包括洛杉矶顶级医生、Vitals.com 的患者选择奖以及 Vitals.com 的富有同情心的医生认可。

教育

  • 本科：加州大学洛杉矶分校
  • 医学院：南加州大学
  • 住院医师：妇产科
  • 南加州大学洛杉矶县
  • 妇幼医院
  • 奖学金：洛杉矶县 + 南加州大学医学中心
  • 妇幼医院妇产科生殖内分泌不孕科

附属医院

  • 洛斯罗伯斯地区医疗中心
  • 普罗维登斯塔扎纳医疗中心
  • 西山医院

学术

  • 凯克医学院临床助理教授
  • 妇产科
  • 生殖内分泌与不孕科
  • 南加州大学

奖项

  • Vitals.com 2011 年、2009 年的富有同情心的医生表彰
  • 2010 年洛杉矶顶级医生
  • 2009 年、2019 年 Vital.com 的患者选择奖

出版物

Peer Review Journals

  1. Boostanfar R, Jain JK, Mishell DR, Paulson RJ. A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction. Fertility and Sterility. May 2001, Volume 75, No.5, pages 1024-1026.
  2. Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis M, Paulson RJ. The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system. Journal of Assisted Reproduction and Genetics. 2001, Vol. 18, No. 10, pages 548-550.
  3. Tourgeman DE, Boostanfar R, Chang L, Lu J, Stanczyk FZ, Paulson RJ. Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Fertility and Sterility. June 2001, Volume 75, No. 6, Pages 1156-1158.
  4. Slater CC, Zhang C, Hodis HN, Mack WJ, Boostanfar R, Shoupe D, Paulson RJ, FZ Stanczyk. Comparison of Estrogen and Androgen Levels After Oral Estrogen Replacement Therapy. The Journal of Reproductive Medicine. December 2001, Vol. 46, No. 12, pages 1052-1056.
  5. Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman D, Slater C, Francis M, Jain J. Pregnancy in the Sixth Decade of Life: Obstetric Outcomes in Women of Advanced Reproductive Age. JAMA November 2002, Vol. 288 No. 18 2320-2323.
  6. Boostanfar R, Amezcua C, Tourgeman DE, Roy S, Stanczyk FZ, Felix JC, Paulson RJ. The growth effects of raloxifene, estradiol, medroxyprogesterone acetate and progesterone on human endometrial adenocarcinoma cells. Fertility and Sterility January 2003, Volume 79, No. 1, Pages 223-225.
  7. Jain JK, Boostanfar R, Slater, CS, Francis MF, Paulson RJ. Monozygotic Twins and Triplets in Association with Blastocyst Transfer. Journal of Assisted Reproduction and Genetics, April 2004, Volume 21, No. 4, Pages 103-107.
  8. Saadat P, Boostanfar R, Slater CS, Tourgeman DE, Stanczyk FZ, Paulson RJ. Accelerated Endometrial Maturation In the Luteal Phase of Cycles Utilizing Controlled Ovarian Hyperstimulation: Impact of Gonadotropin-Releasing Hormone Agonists vs. Antagonists. Fertility and Sterility July 2004. Volume 82, No. 1, Pages 167-171.
  9. Wang H, Wen Y, Polan M, Boostanfar R, Feinman F, Behr B. Exogenous Granulocyte-Macrophage Colony Stimulating Factor Promotes Follicular Development In The Newborn Rat In Vivo. Human Reproduction, June 2005.
  10. Devroey P, Boostanfar R, Koper NP, Mannaerts BMJ, Ijzerman-Boon PC, Fauser BC. A Double Blind Non Inferiority RCT, Comparing Corifollitropin α and Recombinant FSH During the First Seven Days of Ovarian Stimulation Using a GnRH Antagonist Protocol. Human Reproduction Volume 24, No. 12, Pages 3063-3072, 2009.
  11. Boostanfar R, Mannaerts BMJ, Pang S, Fernandez-Sanchez M, Witjes H, Devroey P/ A Comparison of Live Birth Rates and Cumulative Ongoing Pregnancy Rates Between Europe and North America After Ovarian Stimulation with Corifollitropin Alfa or Recombinant Follicle Stimulating Hormone. Fertility and Sterility Volume June 2012, 97, No. 6, Pages 1351-1358.
  12. VerMilyea MD, Tan L, Anthony JT, Conaghan J, Ivani K, Gvakharia M, Boostanfar R, Baker VL, Suraj V, Chen AA, Mainigi M, Coutifaris C, Shen S. Computer-automated time-lapse analysis results correlate with embryo implantation and clinical pregnancy: A blinded, multi-centre study. Reprod Biomed Online 2014 29, 729-736.
  13. Shapiro D, Boostanfar R, Silverberg K, Yanushpolsky EH. Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer. Reprod Biomed Online 2014 Dec;29 S1-S14.
  14. Boostanfar R, Shapiro B, Levy M, Rosenwaks Z, Witjes H, Stegmann B, Elbers J, Gordon K, Mannaerts B. Large, comparative, randomized double blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization. Fertility and Sterility July 2015, Vol. 104, No 1 Page 94-103.
  15. Boostanfar R, Frederick J. Successful Outcomes of Fresh and Frozen Donor Ovum Cycles among Recipients Using Oral Estradiol and Vaginal Progesterone Gel vs. Intramuscular and Vaginal Progesterone. Journal of Fertilization: In Vitro-IVF-Worldwide, Reproductive Medicine, Genetics and Stem Cell Biology 3: 158.doi:10.4172/2375-4508.1000158.

Chapters

  1. Boostanfar R, Roy S: Genital Herpes. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF（eds.）, Blackwell Science Publications, Boston, Massachusetts.
  2. Boostanfar R, Roy S: Wound Infections. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF（eds.）, Blackwell Science Publications, Boston, Massachusetts.
  3. Boostanfar R, Roy S: Rectovaginal Injuries. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF（eds.）, Blackwell Science Publications, Boston, Massachusetts.
  4. Boostanfar R, Stanczyk F, Paulson RJ, Roy S: Diagnosis of Pregnancy. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF（eds.）, Blackwell Science Publications, Boston, Massachusetts.
  5. Saadat P, Boostanfar R, Roy S: Postpartum Endometritis. In:
    Management of Common Problems in Obstetrics and Gynecology. Fourth
    Edition. Mishell DR Jr, Goodwin TM, Brenner PF（eds.）, Blackwell
    Science Publications, Boston, Massachusetts.

Scientific

  1. Kjos SL, Boostanfar R, Pezeshki K, Rafi I, Sanchez L, Bernstein GS, Kovacs A. Effects of medroxyprogesterone acetate on CD4 levels in HIV positive women. Presented at the Association of Reproductive Health Professionals, 1994. Washington D.C.
  2. Pezeshki K, Boostanfar R, Kjos SL. High estrogen dose oral contraceptives in women using anti-epileptic drugs may not protect against pregnancy. Presented at the Association of Reproductive Health Professionals, 1994. Washington D.C.
  3. Boostanfar R, Jain JK, Paulson RJ, Mishell DR Jr. A randomized trial comparing clomiphene citrate with tamoxifen for ovulation induction in obese anovulatory women. Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 15-18, 1999, La Costa, California.
  4. Boostanfar R, Amezcua C, Tourgeman DE, Roy S, Stanczyk FZ, Felix J. The growth inhibitory effects of raloxifene on human endometrial adenocarcinoma ishikawa cells. Presented at the Society for Gynecologic Investigation, March 22-25, 2000, Chicago, Illinois.
  5. Boostanfar R, Jain JK, Tourgeman DE, Slater CC, Francis MM, Paulson RJ. Blastocyst transfer is associated with an increased rate of monozygotic twins. Presented at the 48th Annual meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.
  6. Boostanfar R, Jain JK, Paulson RJ, Mishell Dr Jr. A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction. Presented at the 56th Annual Meeting of the American Society of Reproductive Medicine, October 21-26, 2000, San Diego, California.
  7. Saadat P. Boostanfar R, Stanczyk FZ, Paulson RJ, Buckwalter G, Roy S. Effects of conjugated estrogens and medroxyprogesterone acetate or micronized progesterone on mood, libido and serum endocrine markers in postmenopausal women. Presented at the 56th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 2, 2001, Los Angeles, California.
  8. Boostanfar R, Tourgeman, D, Amezcua C, Goharkay N, Roy S, Stanczyk FZ, Felix J. The comparative effects of raloxifene and progestins on endometrial adenocarcinoma cells in vitro. Presented at the 56th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 2, 2001, Los Angeles, California.
  9. Tourgeman DE, Boostanfar R, Chang L, Lu J, Stanczyk FZ, Paulson RJ. Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Presented at the 56th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 2, 2001, Los Angeles, California.
  10. Boostanfar R, Melnik M, Amezcua C, Roy S, Stanczyk FZ, Felix J. The growth effects of raloxifene, medroxyprogeterone acetate and progesterone on human endometrial adenocarcinoma ishikawa cells. Presented at the Society for Gynecologic Investigation, March 21-24, 2001, Toronto, Canada.
  11. Boostanfar R, Jain JK, Tourgeman DE, Slater CC, Francis MM, Paulson RJ. High order multiple gestations as a result of monozygotic twinning associated with advanced embryo culture and blastocyst transfer. Presented at the Society for Gynecologic Investigation, March 21-24, 2001, Toronto, Canada.
  12. Saadat P. Boostanfar R, Stanczyk FZ, Paulson RJ, Buckwalter G, Roy S. Efffect of hormone replacement therapy containing medroxyprogesterone acetate or micronized progesterone on mood, libido and serum endocrine markers in postmenopausal women. Presented at the Society for Gynecologic Investigation, March 21-24, 2001, Toronto, Canada.
  13. Tourgeman DE, Lu JJ, Boostanfar R, Zheng W, Stanczyk FZ, Felix J, Paulson RJ. Gonadotropin modulation of ovarian neoplastic cell proliferation in vitro. . Presented at the 49th Annual meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  14. Boostanfar R, Jain JK. Pregnancy outcome and clomiphene citrate dose. Presented at the 49th Annual meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  15. Boostanfar R, Sorenson L, Ambroggio J, Jain JK, Slater CC, Francis MM, Paulson RJ. Pregnancy outcome in women 50 or more years of age: A decade of experience. Presented at the 49th Annual meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  16. Tourgeman DE, Amezcua, Boostanfar R, Stanczyk FZ, Felix J, Paulson RJ. Agonistic effects of raloxifene on ovarian adenocarcinoma（OVCAR-3） cells. Presented at The European Society of Human Reproduction and Embryology, July 1-4, 2001 Lausanne, Switzerland.
  17. Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis M, Paulson RJ. The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system. Presented at The European Society of Human Reproduction and Embryology, July 1-4, 2001 Lausanne, Switzerland.
  18. Boostanfar R, Campeau JD, Saadat P, Jain JK, Slater CC, Tourgeman DE, diZerega GS, Kobak WH. Use of the Harmonic Scalpel as a novel technique for distal neosalpingostomy. Presented at the American Association of Gynecologic Laparoscopists, November 16-19, 2001 San Francisco, Cailfornia.
  19. Boostanfar R, Saadat P, Poysky J, Stanczyk FZ, Buckwalter G, Roy S. Serum endocrine markers and psychosexual mood in postmenopausal women: is there a difference between transdermal and oral HRT? Presented at the 57th Annual Meeting of the American Society of Reproductive Medicine, October 20-25, 2001, Orlando, Florida.
  20. Saadat P, Boostanfar R, Poysky J, Stanczyk FZ, Buckwalter G, Roy S. Cognitive Function during hormone replacement therapy. Presented at the Society for Gynecologic Investigation, March 20-23, 2002, Los Angeles, California.
  21. Boostanfar R, Abbassi D, Tourgeman DE, Saadat P, Jain JK, Mishell DR, Paulson RJ. The comparative efficacy of Tamoxifen and Clomiphene Citrate in obese and non-obese women: A prospective randomized trial. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.
  22. Boostanfar R, Saadat P, Klumph S, Slater C, Jain JK, Paulson RJ. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of GnRH agonists vs. antagonists. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.
  23. Saadat P, Boostanfar R, Mor E, Stanczyk FZ, Paulson RJ, Buckwalter G, Roy S. The effects of oral and transdermal hormone replacement therapy on serum free testosterone levels in postmenopausal women. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.
  24. Saadat P, Boostanfar R, Poysky J, Stanczyk FZ, Buckwalter G, Roy S. A randomized prospective study comparing the effects of micronized progesterone and medroxyprogesterone acetate on mood and libido. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.
  25. Hsieh K, Boostanfar R, Slater CC. Distal Tubal Neosalpingostomy; A Retrospective Analysis of Laparoscopy vs. Laparotomy. Presented at University of Southern California Medical Research Symposium, April 24, 2002.
  26. Roy S, Boostanfar R, Saadat P, Poysky J, Stanczyk FZ, Buckwalter G. Serum Endocrine Markers and Pyscholsexual Mood in Postmenopausal Women: The Difference Between Transdermal and Oral HRT. Presented at the Berlin World Congress on the Menopause. June 13, 2002.
  27. Boostanfar R, Abbassi D, Tourgeman DE, Saadat P, Jain JK, Mishell DR, Paulson RJ. The comparative efficacy of Tamoxifen and Clomiphene Citrate in obese and non-obese women: A prospective randomized trial. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.
  28. Mor E, Boostanfar R, Saadat P, Tourgeman DE, Slater CC, Paulson RJ. Pregnancy outcome at the upper extreme of reproductive range: A comparison of two recipient groups. Presented at the 58th Annual Meeting of the American Society of Reproductive Medicine, October 12-17 2002, Seattle, Washington.
  29. Saadat P, Boostanfar R, Abbassi D, Tourgeman DE, Jain JK, Mishell DR, Paulson RJ. The effects of Tamoxifen and Clomiphene Citrate in obese and non-obese women: A randomized trial. Presented at the 71st Anniversary Pacific Coast Obstetrical and Gynecological Society, October 22-27, 2002, Rancho Mirage, California.
  30. Boostanfar R, Saadat P, Abbassi D, Tourgeman DE, Jain JK, Mishell DR, Paulson RJ. The effects of Tamoxifen and Clomiphene Citrate in obese and non-obese women: A randomized trial. Presented at the 58th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 14, 2003, Los Angeles, California.
  31. Boostanfar R, Ivakhnenko V, Potter D, Feinman M, Behr B. Preimplantation genetic diagnosis after density gradient separation of the X and Y-bearing human spermatozoa. Presented at the 51st Annual meeting of the Pacific Coast Reproductive Society, April 24-27, 2003, Rancho Mirage, California.
  32. Feinman M, Boostanfar R, Le A, Potter D, Khoury C, Behr B. Culturing cryopreserved cleavage stage embryos to blastocysts is a cost-effective method of utilizing frozen embryos. Presented at the 60th Annual Meeting of the American Society of Reproductive Medicine, October 16-20 2004, Philadelphia, PA.
  33. Feinman M, Boostanfar R, A. Le, C. Gao. A comparison of down-regulation vs. antagonist protocols in ovum donor cycles… Presented at the 60th Annual Meeting of the American Society of Reproductive Medicine, October 16-20 2004, Philadelphia, PA.
  34. Wang H, Le A, Boostanfar R, Feinman M, Behr B. Regulation of CYP17 Expression in Theca-Interstitial Cells by GM-CSF. Presented at the 53rd Annual meeting of the Pacific Coast Reproductive Society, May 4-8, 2005, Indian Wells, California.
  35. Wang H, Le A, Boostanfar R, Feinman M, Behr B. The Clinical Outcomes of Cryopreserved Pronuclear Embryos from Standard IVF and ICSI. Presented at the 53rd Annual meeting of the Pacific Coast Reproductive Society, May 4-8, 2005, Indian Wells, California.
  36. Wang H, Le A, Boostanfar R, Feinman M, Behr B. Postthaw Embryo Compaction is Predictive of the Success of Frozen-Thawed Transfer. Presented at the 2005 Conjoint Annual Meeting of the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society, October 15-19 2005, Montreal, Quebec.
  37. Boostanfar R, Feinman M, Le A, Wang H, Behr B. Office Administration of Single Dose GnRH Antagonist: Minimizing Patient Injections Utilizing a Simple and Highly Effective IVF Protocol. Presented at the 2005 Conjoint Annual Meeting of the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society, October 15-19 2005, Montreal, Quebec.
  38. Boostanfar R, Ivakhnenko V, Le A, Feinman M, Behr B, Potter D. MicroSort and P.G.D.: Separating the Boys from the Girls. Presented at the 54th Annual meeting of the Pacific Coast Reproductive Society, April 26-30, 2006, Indian Wells, California.
  39. Le A, Boostanfar R, Feinman M, Wang H, Behr B. Comparison of Ultrasound Guided and Traditional Blind Embryo Transfer on Pregnancy Rate Outcome. Presented at the 54th Annual meeting of the Pacific Coast Reproductive Society, April 26-30, 2006, Indian Wells, California.
  40. Boostanfar R, Tourgeman D, Feinman M. Patient Friendly IVF- A Gonadotropin Stimulation Protocol of 10 Injections Total. Presented at the 55th Annual meeting of the Pacific Coast Reproductive Society, April 18-22, 2007, Rancho Mirage, California.
  41. Boostanfar R, Koper N.P, Devroey P, Fauser B.C, Ijzerman-Boon P.C, Mannaerts B, Corifollitropin Alfa Demonstrates Similar Pregnancy Rates As Compared To Daily Recombinant FSH Treatment In A Controlled Ovarian Stimulation Regimen For IVF/ICSI, Presented at the 2008 American Society of Reproductive Medicine , November 8-12, 2008, San Francisco, California.
  42. Boostanfar R, Witjes, Mannaerts B, Gordon K, Mahony M, Clinical Outcomes with a Fixed rFSH/GnRH Antagonist Protocol in a Large North American Cohort of IVF/ICSI Patients. Presented at the 58th Annual meeting of the Pacific Coast Reproductive Society, April 16-20, 2010, Indian Wells, California.
  43. Boostanfar R, Devroey P, Oberye J, Mannaerts B, No Difference in the Cummulative Pregnancy Rates or Live Birth Rates When Comparing Corifollitropin Alfa With Daily rFSH Treatment for COS. Presented at the 26th Annual meeting of the European Society of Human Reproduction and Embryology, June 27-30, 2010 Rome, Italy.
  44. Boostanfar R, Mannaerts B, Witjes H, Devroey P, International Differences in IVF Live Birth Rates and Cumulative Ongoing Pregnancy Rates Following Ovarian Stimulation with Corifollitropin Alfa or Recombinant FSH. Presented at the 2011 American Society of Reproductive Medicine, October 15-19, 2011, Orlando, Florida.
  45. Boostanfar R, Contemporary Outcomes of Fresh Donor Ovum Cycles Among Recipients Using Oral Estradiol and Vaginal Progesterone Gel. Presented at the 60th Annual meeting of the Pacific Coast Reproductive Society, April 11-15, 2012, Rancho Mirage, California.
  46. Shen S, Chen AA, Willman SP, Chenette PE, Boostanfar R, Baker VL, Abusief M, Suraj V, Wirka K, Loewke K, Early Cell Cycle Durations Detected by Time-Lapse Imaging Predicts Embryo Developmental Potential. Presented at the 28th Annual meeting of the European Society of Human Reproduction and Embryology, July 1-4, 2012 Istanbul, Turkey.
  47. Chen AA, Loewke K,Willman SP, Chenette PE, Boostanfar R, Shen S, Prediction of Embryo Viability Using Validated Cell Division Time Intervals Measured by Time-Lapse Imaging. Presented at the 2012 American Society of Reproductive Medicine, October 20-24, 2012, San Diego, California.
  48. Boostanfar R, Yeko T, Shapiro B, Elbers J, Witjes H, Mannaerts BMJ, A Large Double-Blind Efficacy and Safety Trial of Corifollitropin Alfa Versus Daily Recombinant FSH In Women 35 to 42 Years Of Age Undergoing Ovarian Stimulation Prior to IVF or ICSI（Pursue Trial）. Presented at the 2012 American Society of Reproductive Medicine, October 20-24, 2012, San Diego, California.
  49. Boostanfar R, Gordon K, et al. North American IVF Live Birth Rates Stratified by Age and Ovarian Stimulation Compound: Data from the Pursue and Engage Trials. Presented at the 62nd Annual meeting of the Pacific Coast Reproductive Society, March 19-23, 2014, Indian Wells, California.
  50. Gordon K, Boostanfar R, et al. Adverse Events and OHSS by Age Category in IVF Centers in North America: Data from the Pursue and Engage Trials . Presented at the 60th Annual meeting of the Pacific Coast Reproductive Society, March 19-23, 2014, Indian Wells, California.
  51. Boostanfar R, Frederick J. Successful Outcomes of Fresh and Frozen Donor Ovum Cycles Among Recipients Using Oral Estradiol and Vaginal Progesterone Gel Vs. Intramuscular and Vaginal Progesterone. Presented at the 2014 American Society of Reproductive Medicine, October 20-22, 2014, Honolulu, Hawaii.
  52. Boostanfar R, Pang S, et al. Follicular Growth and Endocrine IVF Cycle Characteristics During Ovarian Stimulation in Older Women. Presented at the 63rd Annual meeting of the Pacific Coast Reproductive Society, March 11-15, 2015, Rancho Mirage, California.